Current research on respiratory viral infections: Fifth International Symposium

Michael G. Ison, Sebastian L. Johnston, Peter Openshaw, Brian Murphy, Frederick Hayden*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)75-110
Number of pages36
JournalAntiviral Research
Volume62
Issue number3
DOIs
StatePublished - Jun 2004

Funding

The Scientific Advisory Board for the meeting included Frederick Hayden (University of Virginia) and Brian Murphy (National Institute of Allergy and Infectious Diseases, National Institutes of Health), the co-chairs of the meeting and Larry Anderson (CDC), Robert Couch (Baylor College of Medicine), Sebastian Johnston (National Heart and Lung Institute, Imperial College), Yoshihiro Kawaoka (Universities of Wisconsin and Tokyo), Linda Lambert (NIAID, NIH), Peter Openshaw (Imperial College London, St. Mary’s Campus), and Albert Osterhaus (Erasmus University). Agouron Pharmaceuticals, Inc., Pfizer Co., Aventis Pasteur, F. Hoffmann-La Roche Ltd., MedImmune, Inc., Solvay Pharmaceuticals B.V., ViroPharma Inc., Wyeth Vaccines and The Macrae Group provided educational grants for this meeting.

ASJC Scopus subject areas

  • Virology
  • Pharmacology

Cite this